GlassScriptPhysician profile
Steven Lewis Greenberg
NPI 1639165673
$2,874.99
in general payments reported to CMS, 2019-2025
42 companies · $561 in 2025
The $561 reported for 2025 was more than what 83% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $478 · 2020: $32.07 · 2021: $82.30 · 2022: $523 · 2023: $520 · 2024: $678 · 2025: $561.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,760.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,759.65 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $409.99 | 2019-2024 | |
| Astellas Pharma US INC | $203.54 | 2023-2025 | Veozah |
| Coopersurgical, INC. | $178.95 | 2023-2024 | Endosee, Mara Console, Paragard T 380a |
| Sage Therapeutics, LLC | $172.34 | 2019-2025 | Zurzuvae |
| Bayer Healthcare Pharmaceuticals INC. | $148.72 | 2019-2025 | |
| Pfizer INC. | $131.76 | 2021-2024 | |
| Shield Therapeutics INC | $114.37 | 2023-2025 | Accrufer |
| Sumitomo Pharma America, INC. | $111.68 | 2023 | Myfembree |
| Mayne Pharma Commercial LLC | $110.27 | 2024-2025 | |
| Myovant Sciences INC. | $106.50 | 2021-2022 | |
| Millicent US INC | $94.00 | 2024-2025 | Intrarosa, Femlyv |
| Duchesnay USA Incorporated | $83.24 | 2019 | |
| Exeltis, USA INC. | $74.00 | 2024-2025 | Slynd |
| Merck Sharp & Dohme LLC | $65.07 | 2019-2024 | Gardasil 9, Gardasil |
| Therapeuticsmd, INC. | $64.08 | 2019-2022 |
Show all 42 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Baxter Healthcare | $63.37 | 2019-2023 | Tisseel |
| Ethicon US, LLC | $57.57 | 2021-2023 | Vistaseal, Dermabond Prineo, Ethicon |
| Smith+Nephew, INC. | $53.58 | 2024-2025 | Pico 14 |
| Hologic Sales and Service, LLC | $47.37 | 2024-2025 | Acessa Provu System, Myosure Tissue Removal Device |
| Pacira Pharmaceuticals Incorporated | $46.78 | 2019-2022 | |
| Organogenesis INC. | $44.79 | 2023-2024 | Puraply |
| Solventum Corporation | $41.60 | 2025 | Prevena |
| Ascend Therapeutics US, LLC | $39.65 | 2022 | |
| Evofem Biosciences, INC. | $39.29 | 2022 | |
| Organon LLC | $38.60 | 2023-2024 | Nexplanon |
| Channel Medsystems, INC. | $38.13 | 2022 | |
| Mylan Pharmaceuticals INC. | $37.18 | 2022 | |
| Covidien LP | $26.93 | 2019 | |
| Optumhealth Care Solutions, LLC | $24.53 | 2025 | Eitan Medical, Vivify Health Care Team Portal 001 |
| Supernus Pharmaceuticals, INC. | $19.20 | 2025 | Qelbree |
| Medtronic, INC. | $19.07 | 2023 | Truclear |
| Minerva Surgical, INC | $18.57 | 2022 | |
| Guard Medical INC. | $18.24 | 2025 | Npseal |
| Olympus America INC. | $17.38 | 2019 | |
| Daiichi Sankyo INC. | $16.70 | 2019 | |
| Meditrina | $15.96 | 2023 | |
| Alydia Health | $14.79 | 2021 | |
| Gynesonics, INC. | $14.49 | 2024 | Sonata Sonography-Guided Transcervical Fibroid Ablation System |
| Heron Therapeutics, INC. | $13.61 | 2023 | Zynrelef |
| Avion Pharmaceuticals | $13.32 | 2019 | |
| Teleflex LLC | $13.13 | 2019 | |
| Avanos Medical | $12.65 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Steven Greenberg listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.